Chagas disease (CD) affects over 300 000 people in the USA, many with limited access to healthcare. Although early detection and treatment prevents life-threatening complications, <1% of people with CD receive diagnosis, and routine screening is virtually nonexistent in the USA. We describe a program that led to an increase in CD screening in the Latin American-born population of Los Angeles.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pt.2017.07.003DOI Listing

Publication Analysis

Top Keywords

chagas disease
8
community-based screening
4
screening program
4
program chagas
4
disease usa
4
usa chagas
4
disease 300
4
300 000
4
000 people
4
people usa
4

Similar Publications

Background: Trypanosoma cruzi is a protozoan parasite which causes Chagas disease. Mother-to-child transmission is the main route of transmission in vector-free areas. Congenital Chagas disease refers specifically to cases arising from this route of transmission.

View Article and Find Full Text PDF

Rapid urbanization and migration in Latin America have intensified exposure to insect-borne diseases. Malaria, Chagas disease, yellow fever, and leishmaniasis have historically afflicted the region, while dengue, chikungunya, and Zika have been described and expanded more recently. The increased presence of synanthropic vector species and spread into previously unaffected areas due to urbanization and climate warming have intensified pathogen transmission risks.

View Article and Find Full Text PDF

A new quantitative reverse transcription PCR assay to improve the routine diagnosis of paracoccidioidomycosis.

Med Mycol

January 2025

Mycology Department, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Institut Pasteur, Université Paris Cité, Paris, France.

Paracoccidioides are dimorphic fungal pathogens and the etiological agents of paracoccidioidomycosis (PCM). This severe systemic mycosis is restricted to Latin America, where it has been historically endemic. Currently, PCM presents the fewest diagnostic tools available when compared to other endemic mycoses.

View Article and Find Full Text PDF

This study aimed to investigate the dissemination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in water samples obtained during the coronavirus disease 2019 pandemic period, employing cross-assembly phage (crAssphage) as a fecal contamination biomarker and next-generation sequencing protocols to characterize SARS-CoV-2 variants. Raw wastewater and surface water (stream and sea) samples were collected for over a month in Rio de Janeiro, Brazil. Ultracentrifugation and negatively charged membrane filtration were employed for viral concentration of the wastewater and surface water samples, respectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!